Back
Intra-Cellular Therapies Stock Price Chart
The little-known AI stock you need to read about now...
Get the name - FREE.
Sell
50
ITCI
Intra-Cellular Therapies
Last Price:
72.19
Seasonality Move:
4.56%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!- The current trend is moderately bullish and ITCI is experiencing slight buying pressure.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.35 | Sell |
| 20-day SMA: | 70.2 | Buy |
| 50-day SMA: | 69.42 | Buy |
| 200-day SMA: | 62.23 | Buy |
| 8-day EMA: | 72.63 | Sell |
| 20-day EMA: | 71 | Buy |
| 50-day EMA: | 69.39 | Buy |
| 200-day EMA: | 63.97 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.49 | Buy |
| Relative Strength Index (14 RSI): | 53.35 | Buy |
| Chaikin Money Flow: | 59492 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.32 - 73.4) | Buy |
| Bollinger Bands (100): | (64.8 - 72) | Buy |
Intra-Cellular Therapies Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 72.13 while ITCI 8-day simple moving average is 74.35, which is a Sell signal.
- The stock price of ITCI is 72.13 while Intra-Cellular Therapies 20-day SMA is 70.20, which makes it a Buy.
- Intra-Cellular Therapies 50-day simple moving average is 69.42 while ITCI share price is 72.13, making it a Buy technically.
- ITCI stock price is 72.13 and Intra-Cellular Therapies 200-day simple moving average is 62.23, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Sell
50
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Sell
The current Intra-Cellular Therapies [ITCI] share price is $72.13. The Score for ITCI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
6.98B
Price in USD:
72.13
Share Volume:
654.42K
Intra-Cellular Therapies 52-Week Range
52-Week High:
84.89
52-Week Low:
45.50
Sell
50
Intra-Cellular Therapies (ITCI)
is a Sell
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 72.13 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 72.13 while ITCI 8-day exponential moving average is 72.63, which is a Sell signal.
- The stock price of ITCI is 72.13 while Intra-Cellular Therapies 20-day EMA is 71.00, which makes it a Buy.
- Intra-Cellular Therapies 50-day exponential moving average is 69.39 while ITCI share price is 72.13, making it a Buy technically.
- ITCI stock price is 72.13 and Intra-Cellular Therapies 200-day simple moving average is 63.97, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.98 per share, and an increase next year of $1.45 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is 1.49, suggesting Intra-Cellular Therapies is a Buy
- Intra-Cellular Therapies Relative Strength Index (RSI) is 53.35, which suggest Intra-Cellular Therapies is overbought
- The Bollinger Bands (25) for Intra-Cellular Therapies is (66.32 - 73.4), which suggest Intra-Cellular Therapies is a Buy
- The Bollinger Bands (100) for Intra-Cellular Therapies is (64.8 - 72), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.